In view of the world-wide epidemic of cancer, which is linked to environmental and life-style factors, there is an unmet medical need in breakthrough concepts to understand the causes of neoplasia.
One possible factor contributing to oncogenesis and tumor progression that has been neglected is the microbiota.
will strive to bring efficient, rapid and cost effective tests to diagnose cancer risk or its relapse.
4th February 2019
17 TEAMS ACROSS
9 european countries
15 million euros